← 產業報告目錄
Mammalian Cell Fermentation Technology Market Size, Share & Trends Analysis Report By Type (Chinese Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation, Medical Research Council Cell Strain - 5 (MRC-5) Fermentation ), Application And End-Use, By Region, And Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-28頁數 180報告編號 INSIGHTACE-45caeb05fa
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2024 to 2031 projection horizon, the worldwide Mammalian Cell Fermentation Technology Market is forecasted to register a CAGR of 5%.
Mammalian Cell Fermentation Technology encompasses a crucial component of the production of biopharmaceuticals because it is frequently utilized to produce a range of biosimilars, enzymes, vaccines, and other biologics. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Mammalian Cell Fermentation Technology Market Snapshot
Chapter 4. Global Mammalian Cell Fermentation Technology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Chinese Hamster Ovary (CHO) Cell Fermentation
5.2.2. Human Embryonic Kidney (HEK) Cell Fermentation
5.2.3. Baby Hamster Kidney (BHK) Cell Fermentation
5.2.4. Murine Myeloma Cell Fermentation
5.2.5. Medical Research Council Cell Strain - 5 (MRC-5) Fermentation
5.2.6. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Monoclonal Antibodies
6.2.2. Recombinant Proteins
6.2.3. Biosimilars
6.2.4. Vaccines
6.2.5. Enzymes
6.2.6. Others
Chapter 7. Market Segmentation 3: by End-use Estimates & Trend Analysis
7.1. by End-use & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-use:
7.2.1. Biopharmaceutical Companies
7.2.2. CMOs & CDMOs
7.2.3. Academic and Research Institutes
Chapter 8. Mammalian Cell Fermentation Technology Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.1.2. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.1.4. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.2.2. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.3. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.2.4. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.3.2. Asia Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.3. Asia-Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.3.4. Asia Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.4.2. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.3. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.4.4. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.5.2. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.3. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.5.4. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific, Inc.
9.2.2. Merck KGaA
9.2.3. Danaher
9.2.4. Lonza
9.2.5. Hoffmann-La Roche Ltd
9.2.6. Sartorius AG
9.2.7. AstraZeneca
9.2.8. Bristol-Myers Squibb
9.2.9. Amgen
9.2.10. Gilead Sciences
9.2.11. Moderna, Inc.
9.2.12. Regeneron Pharmaceuticals
9.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們